Blood markers and fluid measurements in hospitalized heart failure patients
Part of Heart & circulation clinical trials.
This study looks at blood markers and body fluid measurements in people hospitalized for heart failure. It aims to better understand inflammation and fluid status, which may help guide future treatments for heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the hospital for heart failure symptoms.
- Your heart's pumping strength is 40% or higher (called preserved or mildly reduced function).
- You have signs of heart structure changes, like an enlarged left atrium or thick heart muscle.
- You do not have a pacemaker or implantable defibrillator (they can interfere with the measurements).
- You are not on dialysis for kidney disease and do not have active cancer (except treated skin cancer or low-risk prostate cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This study looks at whether certain new blood tests (biomarkers) can help doctors learn more about chronic heart failure. You might be asked for blood samples and health information, and the results could improve how heart failure is understood in the future.
This study uses simple heart tests and blood markers to sort people with chronic heart failure into different risk levels, which may help guide treatment. You may join if you have heart failure symptoms and certain test findings.
This study tests whether a blood test can help doctors choose the best medication for people with chronic heart failure. It aims to improve symptom control and reduce hospital stays.
Hear when a new Inflammation Biomarkers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.